Status:
COMPLETED
Accessibility of the World Health Organization's eTB Catalogue of Recommendations
Lead Sponsor:
McMaster University
Conditions:
Tuberculosis
Eligibility:
All Genders
Phase:
NA
Brief Summary
The World Health Organization's Global Tuberculosis Programme (WHO-GTB) issues evidence-informed guideline recommendations on tuberculosis (TB). These recommendations are used by decision-makers, guid...
Detailed Description
This is a two-arm superiority randomized controlled trial. The primary objective is to compare the accessibility of information between the eTB catalogue (intervention) and WHO TB (comparison). Second...
Eligibility Criteria
Inclusion
- Stakeholders who consider themselves to be users or potential users of tuberculosis (TB) recommendations will be eligible for participation. For the purposes of this trial, a user is defined as someone who has previously accessed TB guidelines, recommendations or policy advice, and a potential user is someone who plans to access TB guidelines, recommendations, or policy advice in the future.
- Participants may be part of any group that has a stake in TB, including the public, healthcare providers, policymakers, or researchers. Participants may be from either low- and middle-income countries (LMIC) or high-income countries (HIC).
- They may also vary in levels of education and previous TB work experience.
Exclusion
- Individuals involved in eTB catalogue development.
Key Trial Info
Start Date :
February 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 29 2021
Estimated Enrollment :
244 Patients enrolled
Trial Details
Trial ID
NCT04745897
Start Date
February 26 2021
End Date
August 29 2021
Last Update
December 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McMaster University
Hamilton, Ontario, Canada, L8S 4L8